---
title: "NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026 | NBP Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295848113.md"
description: "NovaBridge Biosciences (Nasdaq: NBP) announced it will hold a webcast on August 20, 2026, at 9:00 AM ET to discuss its first-half 2026 financial results and provide a corporate update. The event covers progress for the period ended June 30, 2026. The webcast is accessible via provided links and archived on the company's investor relations page for at least 30 days."
datetime: "2026-08-13T13:00:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295848113.md)
  - [en](https://longbridge.com/en/news/295848113.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295848113.md)
generator: "portal-rs"
---

# NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026 | NBP Stock News

See more from StockTitan in Google Search and AI answers.Adds StockTitan as a preferred source · opens Google

Add on Google

ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a global biotechnology company that identifies differentiated innovation and applies disciplined development, financing, and partnering strategies to create value, today announced that it will hold a webcast on Thursday, August 20, 2026 at 9:00 AM ET/9:00 PM China Standard Time to discuss recent corporate progress and financial results for the first half ended June 30, 2026.

**Webcast Information:**

-   Date: Thursday, August 20, 2026
-   Time: 9:00 AM ET/9:00 PM China Standard Time
-   Web Access - China: Click here
-   Webcast Access – All other locations: Click here

The live and archived webcast can also be accessed by visiting the NovaBridge Biosciences website on the Upcoming Events section of the Investors page. A replay of the webcast will be archived for at least 30 days after the event.

**About NovaBridge**

NovaBridge Biosciences (Nasdaq: NBP) is a global biotechnology company advancing a portfolio of therapeutic programs in oncology and ophthalmology.. The Company identifies differentiated therapeutic opportunities, generates value-defining clinical evidence, and applies the development, financing, and partnering strategy best suited to each program.

NovaBridge's portfolio includes programs in oncology and ophthalmology, led by givastomig and VIS-101. The Company's objective is to build a sustainable biotechnology company by repeatedly identifying differentiated innovation, advancing it efficiently, and bringing innovative therapies to patients through the path best suited to each opportunity.

For more information, please visit www.novabridge.com and follow us on LinkedIn.

**NovaBridge Investor & Media Contacts**

NovaBridge Biosciences  
+1-240-745-6330  
IR@novabridge.com

Bill Begien, VP, Investor Relations  
bill.begien@novabridge.com

Jessica Zhang, Director, Public Relations  
jessica.zhang@novabridge.com

### Related Stocks

- [NBP.US](https://longbridge.com/en/quote/NBP.US.md)

## Related News & Research

- [NovaBridge EVP Clinical Development Xu Cong Claire sells 3,282 shares for $0.79 each](https://longbridge.com/en/news/297703075.md)
- [Marisa updates financial events calendar for 2026](https://longbridge.com/en/news/297913424.md)
- [LyondellBasell announces dividend of R$ 1.72 per unit for 3Q 2026](https://longbridge.com/en/news/297814383.md)
- [J.M. Smucker announces dividend of R$ 1.94 per unit for Q3 2026](https://longbridge.com/en/news/297931100.md)
- [Wheaton Precious Metals Announces Investor Day Webcast on September 16, 2026 | WPM Stock News](https://longbridge.com/en/news/297699132.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**